IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms12605.html
   My bibliography  Save this article

Mutational signatures of ionizing radiation in second malignancies

Author

Listed:
  • Sam Behjati

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus
    University of Cambridge)

  • Gunes Gundem

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • David C. Wedge

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus
    Oxford Big Data Institute and Oxford Centre for Cancer Gene Research, Wellcome Trust Centre for Human Genetics)

  • Nicola D. Roberts

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Patrick S. Tarpey

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Susanna L. Cooke

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Peter Van Loo

    (The Francis Crick Institute
    University of Leuven)

  • Ludmil B. Alexandrov

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Manasa Ramakrishna

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Helen Davies

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Serena Nik-Zainal

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Claire Hardy

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Calli Latimer

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Keiran M. Raine

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Lucy Stebbings

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Andy Menzies

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • David Jones

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Rebecca Shepherd

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Adam P. Butler

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Jon W. Teague

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Mette Jorgensen

    (University College London Cancer Institute)

  • Bhavisha Khatri

    (Histopathology, Royal National Orthopaedic Hospital NHS Trust)

  • Nischalan Pillay

    (University College London Cancer Institute
    Histopathology, Royal National Orthopaedic Hospital NHS Trust)

  • Adam Shlien

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus
    The Hospital for Sick Children)

  • P. Andrew Futreal

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus
    MD Anderson Cancer Center, University of Texas)

  • Christophe Badie

    (Cancer Mechanisms and Biomarkers Group, Centre for Radiation Chemical and Environmental Hazards, Public Health England)

  • Ultan McDermott

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • G. Steven Bova

    (Institute of Biosciences and Medical Technology, BioMediTech, University of Tampere and Fimlab Laboratories, Tampere University Hospital)

  • Andrea L. Richardson

    (Dana-Farber Cancer Institute
    Brigham and Women's Hospital, Harvard Medical School
    Present address: Sibley Memorial Hospital, Johns Hopkins Medicine, Washington, District Of Columbia 20016, USA)

  • Adrienne M. Flanagan

    (University College London Cancer Institute
    Histopathology, Royal National Orthopaedic Hospital NHS Trust)

  • Michael R. Stratton

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus)

  • Peter J. Campbell

    (Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus
    University of Cambridge)

Abstract

Ionizing radiation is a potent carcinogen, inducing cancer through DNA damage. The signatures of mutations arising in human tissues following in vivo exposure to ionizing radiation have not been documented. Here, we searched for signatures of ionizing radiation in 12 radiation-associated second malignancies of different tumour types. Two signatures of somatic mutation characterize ionizing radiation exposure irrespective of tumour type. Compared with 319 radiation-naive tumours, radiation-associated tumours carry a median extra 201 deletions genome-wide, sized 1–100 base pairs often with microhomology at the junction. Unlike deletions of radiation-naive tumours, these show no variation in density across the genome or correlation with sequence context, replication timing or chromatin structure. Furthermore, we observe a significant increase in balanced inversions in radiation-associated tumours. Both small deletions and inversions generate driver mutations. Thus, ionizing radiation generates distinctive mutational signatures that explain its carcinogenic potential.

Suggested Citation

  • Sam Behjati & Gunes Gundem & David C. Wedge & Nicola D. Roberts & Patrick S. Tarpey & Susanna L. Cooke & Peter Van Loo & Ludmil B. Alexandrov & Manasa Ramakrishna & Helen Davies & Serena Nik-Zainal & , 2016. "Mutational signatures of ionizing radiation in second malignancies," Nature Communications, Nature, vol. 7(1), pages 1-8, November.
  • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12605
    DOI: 10.1038/ncomms12605
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms12605
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms12605?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ewart Kuijk & Onno Kranenburg & Edwin Cuppen & Arne Van Hoeck, 2022. "Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12605. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.